Our analysis of WGBS data from primary AML samples shows that methylation changes caused by these mutations are not widespread but instead manifest as thousands of focal regions that are uniquely hypermethylated compared to normal CD34+ cells and AML cells without IDH mutations. The gene discussed is IDH2; the disease is acute myeloid leukemia.